BMP-23479-37810
4 vaccinations
3 coded responses
53 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 201 / VA
- Registered
- 2021-03-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-11
Registered in v-safe
-
2021-03-11
Dose 1 — Pfizer-BioNTech
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-19
- 2021-03-25
-
2021-04-01
Dose 2 — Pfizer-BioNTech
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-14
- 2021-07-01
-
2021-09-30
Survey response — 6 months, dose 2MedDRA: Exposure to SARS-CoV-2, Fatigue, Oropharyngeal pain, Pyrexia, Rhinalgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: After attending a convention in (b)(6) MD (b)(6) July, I experienced nose and throat soreness, fatigue and a low-grade fever for 2 days. There were reports of several attendees receiving a positive Covid test. Many did not wear masks as that manMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-10-06
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
- 2021-10-10
- 2021-10-11
- 2021-10-18
- 2021-10-26
- 2021-11-01
- 2021-11-08
- 2021-11-16
-
2022-01-03
Survey response — 3 months, dose 3MedDRA: Dizziness, Dysgeusia, Emergency care, Headache, Productive cough, Pyrexia, SARS-CoV-2 test negative — Feeling: Poor · Be unable to do your normal daily activitiesFree text: High fever of 103.4 29Dec21 went to ER neg COVID-19 test result. Fever declined normal today, but dev mild productive cough with odd taste. Intermittent headache with dizziness.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-05
-
2022-05-28
Dose 4 — Pfizer-BioNTech
- 2022-05-28
- 2022-05-29
- 2022-05-30
-
2022-05-31
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-06-01
- 2022-06-02
-
2022-06-03
Health check-in — days 1–6 daily, dose 4Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-06-04
Health check-in — day 7, dose 4Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-06-11
- 2022-06-18
-
2022-06-25
Survey response — day 28, dose 4MedDRA: Asthenia, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue WeaknessMedDRA releases: 2024-11 · check-in free text available
- 2022-07-02
- 2022-07-09
- 2022-08-27
- 2022-11-26
- 2023-05-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-11 | Pfizer-BioNTech | |
| 2 | 2021-04-01 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-05-28 | Pfizer-BioNTech | No |
Free text
Release 9 — 6 months, dose 2
Symptoms: After attending a convention in (b)(6) MD (b)(6) July, I experienced nose and throat soreness, fatigue and a low-grade fever for 2 days. There were reports of several attendees receiving a positive Covid test. Many did not wear masks as that man
redacted (b)(6)
Release 10 — 3 months, dose 3
Symptoms: High fever of 103.4 29Dec21 went to ER neg COVID-19 test result. Fever declined normal today, but dev mild productive cough with odd taste. Intermittent headache with dizziness.
Release 12 — day 28, dose 4
Symptoms: Fatigue Weakness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Dysgeusia | · | · | ✓ |
| SD | Emergency care | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinalgia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release